209 related articles for article (PubMed ID: 2433858)
1. Interaction of C1q subcomponent with immunoglobulin M.
Kimak E; Tomaszewski JJ
Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
3. Failure of oligosaccharide MOPC-104E IgM complexes to bind C1q and to activate C1.
Weiner EM
Biochem Int; 1987 Jul; 15(1):163-8. PubMed ID: 3502595
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
5. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
6. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
[TBL] [Abstract][Full Text] [Related]
8. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
9. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
10. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
11. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
[TBL] [Abstract][Full Text] [Related]
13. Primary macroglobulinemia presenting as multiple ulcers of the legs.
Nishijima S; Hosokawa H; Yanase K; Asada Y; Fujinami S
Acta Derm Venereol; 1983; 63(2):173-5. PubMed ID: 6189341
[TBL] [Abstract][Full Text] [Related]
14. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
16. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
17. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin M possesses two binding sites for complement subcomponent C1q, and soluble 1:1 and 2:1 complexes are formed in solution at reduced ionic strength.
Poon PH; Phillips ML; Schumaker VN
J Biol Chem; 1985 Aug; 260(16):9357-65. PubMed ID: 3926766
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
20. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
